Educational webinar looking at the current Gaucher Disease Type 1 gene therapy trials in collaboration with Freeline and Prevail.
The webinar updates the community on the current GD1 clinical trials. Our global survey highlighted that patients want to see data on safety and efficacy to inform them before they consider gene therapy, and this webinar does exactly that.